NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Overlapping Conditions in IMPACTIntroduction
The IMPACT 1.0 model assumes independence of 119 different medical conditions. That is, it is assumed that one medical event maps to a single medical condition. However, it is often the case that a single medical event may lead to several different concurrent conditions (e.g., a single accident resulting in multiple fractures, chest/abdominal trauma, and sepsis). There is a significant overlap between many of the conditions in ICL 1.0. For example, depression and anxiety are two separate conditions but often co-exist. This overlap may lead to an overestimation in the incidence calculation. In future iterations of the model, we plan to address progression of medical conditions.

Methods
There are two possible methods to approach progression of a medical condition. The first is to take any medical condition in ICL, calculate its incidence and determine its outcomes no matter what sequelae occur. For example, calculate the incidence of prostatitis and determine its metrics (e.g., loss of crew life, risk of medical evacuation or task time affected) no matter what the sequelae might be (sepsis, hydronephrosis, renal failure, etc.). The second approach is to take any medical condition in the ICL and calculate the outcomes based on transitions to any other condition. For example, calculate the incidence of nephrolithiasis and determine the incidence of each possible transition (e.g., hydronephrosis, renal failure, UTI, pyelonephritis, sepsis) and then determine its metrics. With perfectly informative evidence, the answers should be the same using either method. The question is which approach best reduces the opportunity for overlapping.

Results
The team identified 31 conditions that were the most likely to transition to a secondary condition such as sepsis and respiratory failure. It was felt that the first approach, as described above, would be the easiest to implement and would have the greatest reduction in overlapping conditions. The identified conditions were primarily infectious conditions, like UTI and pneumonia (which could lead to both respiratory failure and sepsis), toxic inhalations, cardiac arrest, seizures, and trauma. Once these conditions were identified, the conditions were divided between the four clinicians on the team to identify those that were not consistent with the others in way they were approached. There were 13 conditions that were found to be problematic. Some condition definitions needed to be changed to eliminate references to transitions or to update them in cases where the definitions were out of date. Some conditions required new evidence to correct the loss of crew life, and one condition was felt to have so much overlap that it was recommended for elimination. A second effort required modification of the sepsis incidence calculation to prevent double counting of the conditions, such as prostatitis, that could progress to sepsis.

Conclusion
The team made significant progress in clarifying the method for dealing with transitions from one medical condition to another. In addition, errors were found and corrected in definitions, incidence, and loss of crew life as well as a condition in which reference was made to a CLiFF that was no longer included. These modifications will provide greater fidelity in the IMPACT model and reduce overlap.
Document ID
20230013502
Acquisition Source
Johnson Space Center
Document Type
Conference Paper
Authors
Arian Anderson
(University of Colorado Boulder Boulder, Colorado, United States)
Ariana M. Nelson
(The University of Texas Medical Branch at Galveston Galveston, Texas, United States)
Shean E. Phelps
(The University of Texas Medical Branch at Galveston Galveston, Texas, United States)
Eric L. Kerstman
(The University of Texas Medical Branch at Galveston Galveston, Texas, United States)
Jonathan G. Steller
(The University of Texas Medical Branch at Galveston Galveston, Texas, United States)
David C. Hilmers
(Baylor College of Medicine Houston, Texas, United States)
Date Acquired
September 18, 2023
Subject Category
Aerospace Medicine
Man/System Technology and Life Support
Meeting Information
Meeting: Human Research Program-Investigators Working Group (HRP-IWG)
Location: Galveston, TX
Country: US
Start Date: February 13, 2024
End Date: February 16, 2024
Sponsors: National Aeronautics and Space Administration
Funding Number(s)
CONTRACT_GRANT: NNJ15HK11B
CONTRACT_GRANT: NNX16AO69A
Distribution Limits
Public
Copyright
Portions of document may include copyright protected material.
Technical Review
Professional Review
No Preview Available